Importer of Controlled Substances; Notice of Application, 34162-34163 [E6-9176]

Download as PDF 34162 Federal Register / Vol. 71, No. 113 / Tuesday, June 13, 2006 / Notices jlentini on PROD1PC65 with NOTICES water resources, groundwater resources, biological resources, selenium bioaccumulation, geology and seismicity, energy resources, air resources, agricultural production and economics, land use and soil resources, recreational resources, cultural resources, aesthetics, regional economics, and social issues and environmental justice. Reclamation determined that the action alternatives were unlikely to affect traffic and transportation, noise, utilities and public services, and Indian Trust Assets. Copies of the Final EIS are available for review and inspection at the following public libraries: • Bureau of Reclamation, Denver Office Library, Building 67, Room 167, Denver Federal Center, 6th and Kipling, Denver, CO 80225; telephone 303–445– 2072; • Bureau of Reclamation, Mid-Pacific Regional Library, 2800 Cottage Way, Sacramento, CA 95825; telephone 916– 978–5593; • Natural Resources Library, U.S. Department of the Interior, 1849 C Street, NW., Main Interior Building, Washington, DC 20240–0001; • Alameda County Public Library, 2450 Stevenson Boulevard, Fremont, CA 94538; telephone 510–745–1400; • Contra Costa County Library, 1750 Oak Park Boulevard, Pleasant Hill, CA 94523; telephone 925–646–6434; • Fresno County Public Library, 2420 Mariposa Street, Fresno, CA 93721; telephone 559–488–3195; • Kern County Public Library, 701 Truxton Avenue, Bakersfield, CA 93301; telephone 661–868–0701; • Kings County Public Library, 401 North Douty Street, Hanford, CA 93230; telephone 559–582–0261; • Merced County Public Library, 1312 South 7th Street, Los Banos, CA 95334; telephone 209–826–5254; • San Joaquin County Public Library, 605 North El Dorado Street, Stockton, CA 95334; telephone 209–937–8221; • San Luis Obispo County Public Library Bookmobile, PO Box 8107, San Luis Obispo, CA 93403; telephone for Bookmobile schedule/location 805– 788–2145; • Stanislaus County Public Library, 1500 I Street, Modesto, CA 95354; telephone 209–558–7800; • UC Berkeley Water Resources Center Archives, 410 O’Brien Hall, Berkeley, CA 94720; telephone 510– 642–2666. Additional Information Additional information is available online at https://www.usbr.gov/mp/ sccao/sld/. A Notice of Availability of the Draft EIS was VerDate Aug<31>2005 17:34 Jun 12, 2006 Jkt 208001 published in the Federal Register on June 2, 2005 (70 FR 32370). The Final EIS contains responses to all comments received and reflects comments and any additional information received during the review period. Reclamation’s practice is to make any communication related to proposed projects, including names and home addresses, available for public review. Individual respondents may request that we withhold their home address from public disclosure, which will be honored to the extent allowable by law. There may be circumstances in which a respondent’s identity may also be withheld from public disclosure, as allowable by law. If you wish to have your name and/or address withheld, you must state this prominently at the beginning of your communication. All submissions from organizations or businesses, and from individuals identifying themselves as representatives or officials of organizations or businesses, will be made available for public disclosure in their entirety. Susan L. Ramos, Assistant Regional Director, Mid-Pacific Region. [FR Doc. E6–9184 Filed 6–12–06; 8:45 am] BILLING CODE 4310–MN–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 18, 2005, Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedule II: Drug Schedule Amphetamine (1100) .................... Methylphenidate (1724) ................ Dextropropoxyphene, bulk (nondosage form) (9273). Phenylacetone (8501) .................. Fentanyl (9801) ............................ II II II II II The company plans to manufacture the listed controlled substances in bulk for sales to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance PO 00000 Frm 00111 Fmt 4703 Sfmt 4703 may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than August 14, 2006. Dated: June 7, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–9177 Filed 6–12–06; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on January 26, 2006, Roche Diagnostics Operations, Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis 46250, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in Schedule I & II: Drug Lysergic acid diethylamide (7315) Tetrahydrocannabinols (7370) ..... Cocaine (9041) ............................. Ecgonine (9180) ........................... Methadone (9250) ........................ Morphine (9300) ........................... Alphamethadol (9605) .................. Schedule I I II II II II II The company plans to import the listed controlled substances for the manufacture of diagnostic products for distribution to its customers. E:\FR\FM\13JNN1.SGM 13JNN1 Federal Register / Vol. 71, No. 113 / Tuesday, June 13, 2006 / Notices The company plans to import the listed controlled substances for the manufacture of controlled substances in bulk for distribution to its customers. Any manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than July 13, 2006. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745–46), all applicants for registration to import a basic class of any controlled substance listed in Schedule I or II are, and will continue to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 301.34(b), (c), (d), (e) and (f) are satisfied. Dated: June 7, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–9176 Filed 6–12–06; 8:45 am] BILLING CODE 4410–09–P NATIONAL ARCHIVES AND RECORDS ADMINISTRATION jlentini on PROD1PC65 with NOTICES Records Schedules; Availability and Request for Comments AGENCY: National Archives and Records Administration (NARA). ACTION: Notice of availability of proposed records schedules; request for comments. VerDate Aug<31>2005 17:34 Jun 12, 2006 Jkt 208001 SUMMARY: The National Archives and Records Administration (NARA) publishes notice at least once monthly of certain Federal agency requests for records disposition authority (records schedules). Once approved by NARA, records schedules provide mandatory instructions on what happens to records when no longer needed for current Government business. They authorize the preservation of records of continuing value in the National Archives of the United States and the destruction, after a specified period, of records lacking administrative, legal, research, or other value. Notice is published for records schedules in which agencies propose to destroy records not previously authorized for disposal or reduce the retention period of records already authorized for disposal. NARA invites public comments on such records schedules, as required by 44 U.S.C. 3303a(a). DATES: Requests for copies must be received in writing on or before July 28, 2006. Once the appraisal of the records is completed, NARA will send a copy of the schedule. NARA staff usually prepare appraisal memorandums that contain additional information concerning the records covered by a proposed schedule. These, too, may be requested and will be provided once the appraisal is completed. Requesters will be given 30 days to submit comments. ADDRESSES: You may request a copy of any records schedule identified in this notice by contacting the Life Cycle Management Division (NWML) using one of the following means: Mail: NARA (NWML), 8601 Adelphi Road, College Park, MD 20740–6001. E-mail: requestschedule@nara.gov. FAX: 301– 837–3698. Requesters must cite the control number, which appears in parentheses after the name of the agency which submitted the schedule, and must provide a mailing address. Those who desire appraisal reports should so indicate in their request. FOR FURTHER INFORMATION CONTACT: Laurence Brewer, Director, Life Cycle Management Division (NWML), National Archives and Records Administration, 8601 Adelphi Road, College Park, MD 20740–6001. Telephone: 301–837–1539. E-mail: records.mgt@nara.gov. SUPPLEMENTARY INFORMATION: Each year Federal agencies create billions of records on paper, film, magnetic tape, and other media. To control this accumulation, agency records managers prepare schedules proposing retention periods for records and submit these schedules for NARA’s approval, using the Standard Form (SF) 115, Request for PO 00000 Frm 00112 Fmt 4703 Sfmt 4703 34163 Records Disposition Authority. These schedules provide for the timely transfer into the National Archives of historically valuable records and authorize the disposal of all other records after the agency no longer needs them to conduct its business. Some schedules are comprehensive and cover all the records of an agency or one of its major subdivisions. Most schedules, however, cover records of only one office or program or a few series of records. Many of these update previously approved schedules, and some include records proposed as permanent. No Federal records are authorized for destruction without the approval of the Archivist of the United States. This approval is granted only after a thorough consideration of their administrative use by the agency of origin, the rights of the Government and of private persons directly affected by the Government’s activities, and whether or not they have historical or other value. Besides identifying the Federal agencies and any subdivisions requesting disposition authority, this public notice lists the organizational unit(s) accumulating the records or indicates agency-wide applicability in the case of schedules that cover records that may be accumulated throughout an agency. This notice provides the control number assigned to each schedule, the total number of schedule items, and the number of temporary items (the records proposed for destruction). It also includes a brief description of the temporary records. The records schedule itself contains a full description of the records at the file unit level as well as their disposition. If NARA staff has prepared an appraisal memorandum for the schedule, it too includes information about the records. Further information about the disposition process is available on request. Schedules Pending 1. Department of Commerce, Bureau of Industry and Security (N1–476–06–1, 3 items, 3 temporary items). Inputs, master files, and documentation associated with an electronic information system used to generate alphanumeric identification numbers for the exporting community seeking licenses for dual-use technologies. 2. Department of Commerce, Bureau of Industry and Security (N1–476–06–2, 4 items, 4 temporary items). Inputs, outputs, master files, and documentation associated with an electronic information system used for the submission of export license E:\FR\FM\13JNN1.SGM 13JNN1

Agencies

[Federal Register Volume 71, Number 113 (Tuesday, June 13, 2006)]
[Notices]
[Pages 34162-34163]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9176]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of 
such a substance, provide manufacturers holding registrations for the 
bulk manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on January 26, 2006, Roche Diagnostics Operations, Inc., Attn: 
Regulatory Compliance, 9115 Hague Road, Indianapolis 46250, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of the basic classes of controlled 
substances listed in Schedule I & II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
Cocaine (9041).............................  II
Ecgonine (9180)............................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
Alphamethadol (9605).......................  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
the manufacture of diagnostic products for distribution to its 
customers.

[[Page 34163]]

    The company plans to import the listed controlled substances for 
the manufacture of controlled substances in bulk for distribution to 
its customers.
    Any manufacturer who is presently, or is applying to be, registered 
with DEA to manufacture such basic classes of controlled substances may 
file comments or objections to the issuance of the proposed 
registration and may, at the same time, file a written request for a 
hearing on such application pursuant to 21 CFR 1301.43 and in such form 
as prescribed by 21 CFR 1316.47.
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than July 13, 2006.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e) and (f). As noted in a previous notice published in the Federal 
Register on September 23, 1975, (40 FR 43745-46), all applicants for 
registration to import a basic class of any controlled substance listed 
in Schedule I or II are, and will continue to be required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 
21 CFR 301.34(b), (c), (d), (e) and (f) are satisfied.

    Dated: June 7, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-9176 Filed 6-12-06; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.